US lawmakers launch investigation into FDA approval and price of new Alzheimer's drug
CNN
Two House committees have launched an investigation into the approval and pricing of the Alzheimer's disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm.
The US Food and Drug Administration approved the drug earlier this month under its "accelerated approval" program, although an FDA advisory committee concluded last year that there was not enough evidence to support the effectiveness of the treatment.President Joe Biden on Sunday delivers his first commencement address of the 2024 season at Morehouse College, where the president may for the first time in months have to confront the angst that’s been percolating on college campuses nationwide toward his administration’s policies on the Israel-Hamas war.
Arab and Palestinian Americans left a meeting with Secretary of State Antony Blinken on Friday night frustrated they did not have a clear understanding of how the Biden administration might act upon their concerns as the Israel-Hamas war devastates the civilian population in Gaza, participants told CNN.